NovoCure Limited vs UnitedHealth Group Incorporated — Stock Comparison

NVCR
NovoCure Limited
$16.62
▲ 9.27%
vs
UNH
UnitedHealth Group Incorporated
$368.78
▼ 0.46%
Q·Score Winner
UnitedHealth Group Incorporated
UNH6.3/10vs 5.4/10

Q·Score Breakdown

5.4
Bearish
Overall
6.3
Neutral
1
Quality
6.2
7.4
Health
5.3
6.7
Growth
5.1
6.5
Valuation
7.3
6.8
Sentiment
8.1
NVCR

Healthy balance sheet and financial position.

currently unprofitable (-26% margin).

UNH

82% of 28 covering analysts have a positive rating.

limited growth momentum.

Analyst Consensus

BUY
Target $25.21 (+51.7%)
7 analysts
BUY
Target $387.27 (+5.0%)
26 analysts

Fundamentals

NVCR
UNH
Trailing P/E
27.9×
-14.3×
Forward P/E
17.8×
-25.7%
Profit Margin
2.7%
75.4%
Gross Margin
18.8%
-50.0%
ROE
12.2%
12.3%
Revenue Growth
2.0%
Earnings Growth
0.7%
0.82
Beta
0.41
Price / Book
$1.9B
Market Cap
$334.9B
$10 – $20
52-Week Range
$235 – $410

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →